rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2001-5-8
|
pubmed:abstractText |
We analyze the expression of E-cadherin in bladder transitional cell carcinoma, areas of carcinoma in situ and lymph node metastases, and determine the value of E-cadherin immunoreactivity for predicting disease progression and survival of patients with bladder transitional cell carcinoma.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-5347
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
165
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1473-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11342899-Aged,
pubmed-meshheading:11342899-Aged, 80 and over,
pubmed-meshheading:11342899-Cadherins,
pubmed-meshheading:11342899-Carcinoma, Transitional Cell,
pubmed-meshheading:11342899-Carcinoma in Situ,
pubmed-meshheading:11342899-Cystectomy,
pubmed-meshheading:11342899-Disease Progression,
pubmed-meshheading:11342899-Female,
pubmed-meshheading:11342899-Follow-Up Studies,
pubmed-meshheading:11342899-Humans,
pubmed-meshheading:11342899-Immunohistochemistry,
pubmed-meshheading:11342899-Lymph Nodes,
pubmed-meshheading:11342899-Lymphatic Metastasis,
pubmed-meshheading:11342899-Male,
pubmed-meshheading:11342899-Middle Aged,
pubmed-meshheading:11342899-Neoplasm Invasiveness,
pubmed-meshheading:11342899-Prognosis,
pubmed-meshheading:11342899-Survival Rate,
pubmed-meshheading:11342899-Tumor Markers, Biological,
pubmed-meshheading:11342899-Urinary Bladder Neoplasms
|
pubmed:year |
2001
|
pubmed:articleTitle |
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
|
pubmed:affiliation |
Scott Department of Urology, Baylor College of Medicine, and The Methodist Hospital, Houston, Texas, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|